Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide

BACKGROUND: Lockdown due to the coronavirus disease 2019 (COVID-19) pandemic led to increases in weight in part of the population. Weight gain leads to hepatic steatosis (HS). Antiretroviral treatment could also influence HS in people with human immunodeficiency virus (PWH). The impact of lockdown o...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Marta, Corma-Gómez, Anais, Martin-Carmona, Jesica, Pérez-García, Margarita, Martín-Sierra, Carmen, Rincón-Mayo, Pilar, González-Serna, Alejandro, Pineda, Juan Antonio, Real, Luis Miguel, Macías, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642731/
https://www.ncbi.nlm.nih.gov/pubmed/37965642
http://dx.doi.org/10.1093/ofid/ofad532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642731/
https://www.ncbi.nlm.nih.gov/pubmed/37965642
http://dx.doi.org/10.1093/ofid/ofad532

Ejemplares similares